Point72 Asset Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57M | Buy |
|
|||||
|
2025
Q1 | $47.6M | Buy |
|
|||||
|
2024
Q4 | $63.6M | Buy |
|
|||||
|
2024
Q3 | $53.3M | Sell |
|
|||||
|
2024
Q2 | $71.7M | Buy |
|
|||||
|
2024
Q1 | $53.9M | Sell |
|
|||||
|
2023
Q4 | $109M | Buy |
|
|||||
|
2023
Q3 | $36.9M | Buy |
|
|||||
|
2023
Q2 | $40.2M | Buy |
|
|||||
|
2023
Q1 | $8.26M | Sell |
|
|||||
|
2022
Q4 | $22.5M | Buy |
|
|||||
|
2022
Q3 | $3.79M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $950K | Buy |
|